Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.14 Analyst target: $0.35 Upside: 150.00%
Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.
See the full interactive analysis & chart →Informational only — not investment advice.